Plecanatide vs Glucagon-like peptide-2
Head-to-head comparison of Plecanatide (Plecanatide) and Glucagon-like peptide-2 (Glucagon-like peptide-2) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Plecanatide | Glucagon-like peptide-2 |
|---|---|---|
| Category | Gastrointestinal | Gastrointestinal |
| Full Name | Plecanatide | Glucagon-like peptide-2 |
| Molecular Weight | Approx. 1620 Da | ~3.7 kDa |
| Half-Life | Local intestinal action; systemic half-life not clinically meaningful | ~7 min |
| Amino Acids | 16 | 33 |
| Typical Dose | 3 mg once daily | Research-only dosing varies; native peptide is not routinely used clinically |
| Route | Oral | SC|IV |
| Purity | ≥98% | ≥98% |
| Studies Count | 350 | 90 |
| Research Status | Clinical | Endogenous |
Plecanatide Benefits
- ✓improves-stool-frequency
- ✓supports-fluid-secretion
- ✓may-reduce-constipation
- ✓local-gut-action
Glucagon-like peptide-2 Benefits
- ✓mucosal trophic support
- ✓intestinal barrier repair
- ✓nutrient absorption support
Plecanatide Dosing
3 mg PO daily|take with or without food|avoid when dehydrated
Glucagon-like peptide-2 Dosing
0.5–2 mg/day (research)|SC/IV
Plecanatide Side Effects
- ⚠diarrhea
- ⚠abdominal-discomfort
- ⚠nausea
Glucagon-like peptide-2 Side Effects
- ⚠nausea
- ⚠abdominal fullness
Research Overview
Plecanatide
Clinical trials show plecanatide improves constipation outcomes with a generally favorable tolerability profile. Like linaclotide, it acts locally in the intestinal lumen via GC-C signaling rather than systemic hormone effects.
Glucagon-like peptide-2
Native GLP-2 is a key enteric growth factor with rapid degradation by DPP-4. Its therapeutic value is best known through GLP-2 analog development, but the native peptide itself is a real GI-relevant hormone.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.